Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bepotastine-Fluticasone Combo in Seasonal Allergic Rhinitis
NCT01578278Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Dec 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bepotastine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Bausch + Lomb. Primary endpoint: Total Nasal Symptom Score at 14 days. Started Dec 2011; status: completed.
02
Drugs
bepotastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01578278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578278.